PHILADELPHIA—Patients with chronic kidney disease (CKD) have a relatively high prevalence of gout compared with the general population, according to data presented at Kidney Week 2011.
PHILADELPHIA—Baseline plasma phosphate level is an important risk factor for cardiovascular events and mortality in hemodialysis (HD) patients, investigators reported at Kidney Week 2011.
In a study presented at Kidney Week of 70,662 patients who initiated dialysis at 67 years or older, Deidra C. Crews, MD, of Johns Hopkins Medical Institutions in Baltimore, and colleagues found that a greater burden of comorbidities, frequent nephrology visits, and hospitalization for congestive heart failure were associated with early dialysis initiation.
PHILADELPHIA—Initiating treatment of type 2 diabetes with sulfonylurea drugs is associated with an increased risk of renal function decline, end-stage renal disease (ESRD), or death compared with starting treatment on metformin, according to study findings presented at Kidney Week 2011.
PHILADELPHIA—Coronary artery calcification (CAC) provides additional predictive value for the risk of myocardial infarction (MI) in patients with chronic kidney disease (CKD), according to data presented at Kidney Week 2011.
PHILADELPHIA—Levels of fibroblast growth factor 23 (FGF-23) are elevated in acute kidney injury (AKI) and are associated with an increased risk of death or need for renal replacement therapy (RRT), data presented at Kidney Week 2011 suggest.
PHILADELPHIA—Elevated systolic blood pressure (SBP) contributes substantially to rapid declines in renal function in older adults, investigators reported at Kidney Week 2011.